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ABSTRACT  
Macrophages play a critical role in the establishment of a regulated inflammatory response following 
tissue injury.  Following injury, CCR2
+
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tissue, and direct the initiation and resolution of inflammation that is essential for tissue repair.  In 
pathologic states where chronic inflammation prevents healing, macrophages fail to transition to a 
reparative phenotype.  Using a murine model of cutaneous wound healing, we found that CCR2-
deficient mice (CCR2
-/-
) demonstrate significantly impaired wound healing at all time points post-
injury.  Flow cytometry analysis of wounds from CCR2
-/-
 and wild type mice revealed a significant 
decrease in inflammatory, Ly6C
Hi
 recruited monocyte/macrophages in CCR2
-/-
 wounds.  We further 
show that wound macrophage inflammatory cytokine production is decreased in CCR2
-/-
 wounds.  




 mice demonstrated 




 mice.  Further, 
adoptive transfer of monocyte/macrophages from wild type mice restored normal healing, likely 
through a restored inflammatory response in the CCR2-deficient mice.  Taken together, these data 
suggest that CCR2 plays a critical role in the recruitment and inflammatory response following injury, 











Wound healing is dependent on a tightly regulated immune response to injury.  The early 
inflammatory response, regulated mainly by recruited monocyte-derived macrophages (MoMΦs) 
from peripheral blood, is crucial for establishment of the healing cascade[1],[2].  These recruited 
MoMΦs are key players in establishment of this early inflammatory response, and their plasticity 
allows for the transition from the inflammatory to the regenerative phase of healing[3].  The early 
recruitment of monocytes to the wound is dependent on tracking through chemokine gradients via a 
variety of receptors and signaling molecules.  For example, CCR2 is a chemokine receptor primarily 
found on MoMΦs and is an important for MoMΦ tracking from peripheral blood to injured tissues.  
 
Recruited MoMΦs are responsible for both the initiation and resolution of inflammation due to their 
high plasticity[4]–[7].  Within the murine and human circulation, these essentially exist in one of two 
dominant phenotypes, termed “classical” and “non-classical” MoMΦs.  These phenotypes are 
distinguished by unique patterns of chemokine receptor expression[8].  Classical MoMΦs, often 
characterized as Ly6C
Hi 
cells in mice, express high levels of the chemokine receptor CCR2, whereas 
non-classical MoMΦs express high levels of fractalkine receptor CX3CR1. This nomenclature was 
initially based on the macrophage response to monocyte chemoattractant protein-1 (MCP-1 or CCL2), 





MoMΦs that respond to CCL2, the primary ligand for CCR2.  The CCL2 chemokine functions to 
maintain homeostatic levels of monocytes in circulation as well as to direct the recruitment of 
MoMΦs to sites of tissue injury[11],[12].  Recruitment of Ly6C
Lo
 MoMΦs, however, has not been 
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demonstrate different functional characteristics. Upon entering injured tissue, Ly6C
Hi 
cells assume a 
pro-inflammatory role[13].  There, they begin to secrete pro-inflammatory cytokines, including IL-1β, 
TNF-α, and IL-6[13],[14].  Ly6C
Lo
 cells appear towards the end of the initial inflammatory phase, 
when they demonstrate anti-inflammatory characteristics and promote tissue remodeling, fibrosis, and 
wound healing through the production of TGF-β and IL-10[15]–[17].  In addition to these two 
populations of recruited monocytes, there is a cohort of tissue resident macrophages that are also 
designated as Ly6C
Lo 
cells.  These tissue resident cells express the surface marker F4/80 (F4/80
+
), and 
have been found to be activated following tissue injury or inflammation, triggering their 
differentiation into macrophages[18].  Thus, it is unclear if Ly6C
Lo
 cells are recruited directly from 
circulation[18], are present at baseline levels in the tissues, or if they transition in the wound tissue to 
Ly6C
Lo
 cells from Ly6C
Hi 
cells; regardless, a clear phenotype shift from proinflammatory to anti-
inflammatory has been documented post-injury in many tissues including liver, myocardium, and 
skeletal muscle[13],[18]–[21]. 
 
Deficiency of CCR2 can alter both monocyte homeostasis in the circulation and the recruitment of 
monocytes to sites of tissue injury.  Mice deficient in CCR2 are known to have a deficiency in 
circulating Ly6C
Hi 
cells, as CCR2 is critical for mobilization of monocytes from the bone marrow 
during systemic inflammation[12].  Further, in liver tissues, depletion of CCR2
+
 MoMΦs at different 
stages of injury resulted in dysregulation of inflammation and altered tissue recovery[22]–[24].  While 
the role of CCR2 in healing of myocardium, liver, lungs, skeletal muscle, and other organs is well 
described, the literature regarding the role of CCR2 in cutaneous wound healing is less well-defined.  
It has been well-described that the phenotypic expressions exhibited by MoMΦs follow a clear 
temporal pattern in cutaneous wounds[25], but the relationship of CCR2 to different MoMΦ 
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mediated MoMΦ recruitment occurs after excisional scalp injury in the murine model during the first 
four hours after initial tissue injury, and thus prior to the generation of granulation tissue[26].  
Furthermore, studies by Crane et al and Willenborg et al investigate the role of CCR2 in cutaneous 
wound healing, however these studies examined F4/80
+ 
cells and thus focus on tissue resident 
macrophages rather than recruited monocytes[20],[27].  The latter study also investigates wound 
healing at late tissue injury points, and focuses on the role of resident macrophages in the production 
of angiogenic mediators in tissue repair[27].  Given that CCR2 does play an essential role in MoMΦ 
recruitment and healing in other tissues, we hypothesized that CCR2 would impact recruited MoMΦs 
in cutaneous wound healing, and that deficiency of CCR2 would result in impaired wound healing 
through modulation of the inflammatory response.   
 
In this study, we found that wound healing is impaired in CCR2-deficient mice, and that macrophages 
isolated from these mice demonstrated decreased inflammatory gene expression and protein levels.  





 mice results in significant tracking of monocytes to the site of injury both at 
days 2 and 4, and that transfer of wild type macrophages into CCR2-deficient mice after wounding 
was sufficient to rescue wound healing, likely through restoration of the inflammatory response.  This 
is important, as the ability to modulate inflammation in wounds is translationally relevant given that 
chronic inflammation is often associated with pathologic wound healing.  Our findings suggest that 
CCR2 plays an integral role in recruited monocyte/macrophage-mediated inflammation in wound 
healing and offer a therapeutic target for pathologic inflammation.  
 
RESULTS 
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As has been shown in injured cardiac and hepatic tissues, CCR2’s role in the recruitment of MoMΦs 
is both necessary and time-dependent for proper healing[13],[24].  Consequently, we hypothesized 
that wound healing would be delayed or impaired in mice globally deficient in CCR2 (CCR2
-/-
). To 
investigate this, we wounded CCR2
-/-
 mice and controls (CCR2
+/+
) with a 4mm punch biopsy, and 
measured wound area daily using NIH ImageJ software.  As expected, CCR2
-/- 
mice demonstrated 
significantly impaired wound healing at all time points compared with matched controls (Figure 1A).  
Representative images of mouse wounds are shown in Figure 1.  In order to examine histologic 
changes during healing, day 3 whole wounds were paraffin-embedded and stained with H&E and 
Masson’s trichrome to examine epithelialization and collagen content, respectively.  Figure 1B 
demonstrates both the impaired epithelialization and decreased collagen content in CCR2
-/-
 mouse 
wounds compared with controls.  Collectively, these findings suggest that a global lack of CCR2 
impairs both the inflammatory and reparative phases of wound healing and that failure to establish the 
initial inflammatory phase in wound healing may lead to failure to progress through the subsequent 








Since progression through the inflammatory phase of wound healing is largely directed by 
macrophage plasticity, we theorized that the impaired wound healing during this phase in CCR2-
deficient mice was secondary to decreased influx of monocytes to the wound site and the failure of the 
initial inflammatory response that is necessary for progression through the healing cascade.  Since 
CCR2 is expressed primarily on classically derived, pro-inflammatory macrophages, we hypothesized 
that inadequate early influx of these cells accounts for the impaired wound healing phenotype in 
CCR2-deficient mice.  Work by our group and others has demonstrated that pro-inflammatory 
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transition to the reparative phase of healing[28].  We have shown that absence of initial inflammation 
in wounds halts progression of the wound-healing cascade and prevents healing[29].  In order to 
examine this in our model, we isolated cutaneous wounds from CCR2
-/-
 mice and matched controls 
during the early inflammatory phase, and analyzed these wounds by flow cytometry.  We used a 















 cells, as previously described (Figure 2A)[29],[30].  It has been previously documented by 
our group and others that Ly6C
Hi
 demonstrate a pro-inflammatory phenotype, whereas Ly6C
Lo
 cells 









 wounds, we found that there were significantly fewer 
Ly6C
Hi
 cells in the CCR2
-/-
 cohort (0.21%) compared with controls (4.15%) (Figure 2A).  These 
results suggest that fewer inflammatory Ly6C
Hi
 cells are present in CCR2-deficient wounds during the 
inflammatory phase. 
 
To determine if the differences in the number of Ly6C
Hi
 cells recruited to the wound were due to 





 wounds.  We did not find statistically significant differences in wound CCL2 between CCR2-
deficient mice and controls (Supplemental Figure 1). 
 
CCR2-deficient wound macrophages demonstrate decreased inflammation. 
Macrophage phenotype is identified by cell surface receptors and cell function, often determined by 
intracellular mediator production[15].  In order to examine wound macrophage function, we isolated 
macrophages from cutaneous wounds of CCR2
-/-
 and matched controls on post-injury day 3 and 
analyzed both inflammatory gene expression as well as cytokine production by intracellular flow 
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had adequate time to enter the tissues, transform into macrophages, and assume a functional 
role[34],[35].  Previous studies suggest that recruited macrophage numbers are at their highest levels 
on day 3 postwounding[36].  Macrophages were isolated from wound tissue using magnetic-assisted 








 cells as previously described[37].  Gene 
expression of inflammatory cytokines critical for wound inflammation, including IL1β and TNF-α, 
was examined using quantitative PCR.  As expected, we found significantly decreased expression of 
both IL1β (P<0.001) and TNF-α (P<0.05) in macrophages isolated from CCR2
-/-
 wounds (Figure 3A). 
 
In order to determine if gene expression patterns mirror cytokine production, we isolated wounds 
from CCR2
-/-
 mice and matched controls and examined macrophages using a similar gating strategy 
as described in Figure 2A.  Intracellular staining for inflammatory cytokines and mediators, IL1β, 
TNF-α and iNOS, was performed.   We found that there was significantly decreased IL1β, TNF-α, 
and iNOS in the CCR2
-/-






 cells) compared with 
controls (Figure 3B).  To determine whether changes in neutrophils are present in CCR2
-/-
 versus 





 cell (neutrophil) population.  We found no differences in the percentages of neutrophils in the 
CCR2
-/-
 mice compared with controls, suggesting the differences in inflammatory profiles were not 
due to neutrophils (Supplemental Figure 2.  Taken together, these results suggest that wound 
macrophages lacking CCR2 are less inflammatory, and early healing is impaired due to the lack of 
initial inflammation.   
 
Myeloid-specific CCR2 is sufficient to rescue wound healing. 
In order to determine if CCR2
+
 MoMΦs can restore healing in CCR2-deficient mice by restoring the 
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) were administered via tail vein 
injection to CCR2
-/-
 mice.  Mice were then wounded and wound healing was monitored daily for 9 
days.  We found that wound healing was significantly improved in mice that received CCR2
+/+
 
MoMΦs compared to mice that received CCR2-deficient MoMΦs (Figure 4A).  Figure 4B shows 
representative images of mouse wound areas on days 0, 2, and 4 for comparison between the two 
groups, showing the improved wound healing in the CCR2-deficient mice that received wild type 





 adoptive transfer, we examined gene expression in the MoMΦs from wounds of the 
adoptively transferred mice.  This revealed significantly increased expression of IL1β, TNF-α, and 
iNOS in the CCR2-deficient mice that received wild type macrophages compared with those that did 
not (Figure 4C).  This suggests that myeloid-specific CCR2 was sufficient to rescue wound healing in 
these mice, likely by restoring the initial inflammatory phase necessary for proper wound healing. 
To ensure that the macrophages we injected tracked to the wound and thus comprised a significant 






















mice.  We examined wounds on day 2 and 4 and saw a 





















 mice.  This percentage increased significantly from day 2 to 4 (Figure 




populations in wounds from the adoptively 
transferred mice, we found that CCR2
-/-





















) cells in their wounds, suggesting there 
were more recruited cells in this cohort.  Taken together, these results suggest that there is increased 
recruitment of MoMΦs to CCR2
-/-
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In this study, we investigated the role of CCR2 in MoMΦ recruitment and the initiation of the 
inflammatory phase of wound healing.  We found that CCR2 is crucial for initial monocyte 
recruitment and for regulated wound healing.  CCR2-deficient mice demonstrated significantly 
impaired wound healing, particularly during the early inflammatory phase, when recruitment of 
inflammatory cells is crucial for the initiation of the healing cascade and directs the subsequent 
progression of healing.  Additionally, our results show that wound macrophages from CCR2-deficient 
mice display decreased expression of well-established proinflammatory mediators that are critical for 
normal tissue repair.  Furthermore, when myeloid-specific CCR2 was replenished in the CCR2-
deficient mice via adoptive transfer, wound healing was restored in these mice, suggesting that 
myeloid-specific CCR2 was both necessary and sufficient to rescue wound healing.  In addition, upon 
analysis of wound macrophages isolated from CCR2
-/-
 mice receiving wild type (CCR2
+/+
) MoMΦs, 
gene expression of key inflammatory mediators (IL1β, TNF-α, and iNOS) was restored.  Taken 
together, these results suggest that CCR2 and recruited MoMΦs are necessary to mount the 
appropriate inflammatory response crucial for successful wound healing.  Figure 5 depicts a summary 
diagram of CCR2-mediated recruitment. 
 
The role of CCR2 in tissue repair has been investigated in liver and the myocardium[13],[24].  In the 
setting of liver injury, Dal-Secco et al found that fluorescent-labeled classical monocytes were 
recruited to the site of injury within the first 48 hours, forming a ring around the injury site[13].  
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to the injury site.  Similar findings were demonstrated in a murine model of cardiac injury, where an 
initial influx of CCR2
+
 monocytes occurred post-injury[24].  Interestingly, in a related study, Lavine 
et al revealed that blocking CCR2, and thus preventing recruitment to the tissue post-injury, improved 
cardiac remodeling[38]. 
 
While the role of CCR2 in tissue healing has been investigated in liver, cardiac tissues, skeletal 
muscle, and in healing of bone fractures, the majority of the studies examining the role of CCR2 in 
cutaneous wound healing revolve around tissue resident macrophage populations.  For example, 
Willenborg et al used a similar model to our studies utilizing excisional punch biopsies; however, 
these authors examined F4/80
+
 resident macrophage inflammation and proangiogenic factors[27].  
Interestingly, their results within the F4/80
+
 cell population mirrored the inflammatory profile of the 
recruited MoMΦs we examined in our study; that is, that CCR2 is necessary for the initial 
macrophage-mediated inflammatory response in skin wounds.  They further concluded that it is these 
cells that give rise to a highly proangiogenic, VEGF-expressing macrophage subset[27].  A study by 
Crane et al also investigated the F4/80
+
 resident macrophage response to foreign body inflammation 
using subcutaneously implanted polyvinyl alcohol sponges[20].  In contrast, our work focuses on the 
effect of CCR2 on recruited circulating MoMΦ populations.  We chose not to specifically target the 
F4/80
+
 resident macrophage population given that these macrophages are thought to populate the 
tissues prior to birth and are replaced through self-renewal, making their full characterization in 
granulation tissue lower yield[6],[32].  Furthermore, in one of our recent publications, we compared 
differences in Ly6C populations with and without inclusion of F4/80
+
 cells in our flow cytometry 
gates, and found no significant differences.  This is most likely because following injury, the 







This article is protected by copyright. All rights reserved. 
 
12 
To our knowledge, the only study in the literature to date regarding the role of CCR2 in circulating 
monocyte populations in cutaneous wound healing is by Rodero et al[26].  These authors developed a 
new model for real-time in vivo imaging of recruited monocyte populations after murine excisional 
scalp injury.  They found a complete abrogation of monocyte infiltration in early wounds in CCR2-
deficient mice.  While these findings corroborate our findings, suggesting CCR2 is necessary for 
recruitment of circulating monocytes to the wound, their study only looked at the first four hours post-
injury.    
  
Our study is the first to examine the role of CCR2 in the initial inflammatory response of recruited 
circulating MoMΦs in wound healing.  As expected, our flow cytometry results demonstrated 
decreased Ly6C
Hi
 cells in our CCR2
-/-
 wounds; however, interestingly the CCR2
-/-
 wounds 
demonstrated a significant increase in Ly6C
Lo
 cells.  The reason for this increase in Ly6C
Lo
 cells is 
unknown; however, some studies suggest that Ly6C
Lo
 cells are derived from Ly6C
Hi 
cells after day 3 
post-injury [13],[24],[38], while other studies suggest a separate wave of monocyte influx after day 
3[39].  Thus, as the CCR2
-/-
 mice expressed a predominance of Ly6C
Lo
 cells, yet were unable to 
recruit Ly6C
Hi
 cells, this suggests that a separate Ly6C
Lo
 influx may occur.  Alternatively, and more 
likely, the Ly6C
Lo
 cells in this cohort may represent tissue resident macrophages, a population of cells 
that also expresses Ly6C
Lo
 within cutaneous wounds. 
 
Although our study suggests that CCR2 is necessary for the initial inflammatory response, there are a 
few limitations that should be addressed.  While we examined macrophage-mediated inflammation in 
wound healing, there are other factors that play a role in this complex process. Although monocytes 
appear to be the predominant cell expressing the CCR2 receptor, there has been recent evidence that 
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neutrophils play a key role in the early stages of wound healing, it is possible that some of the healing 
deficits seen in our global CCR2
-/-
 knockouts are mediated by neutrophils, although we did not detect 
differences in the neutrophil population.  Additionally, since our studies focused specifically on 
recruited macrophage populations rather than tissue resident macrophages, it is possible that F4/80
+
 
resident macrophages also contribute to the changes in healing seen in our experiments.  Since the 
macrophage response to injury is complex, further studies are needed to determine the specific cells 
and genes that are critical for healing.  It is clear that there are redundant pathways that contribute to 
inflammation post-injury. 
 
To our knowledge, our study is the first to examine the role of CCR2 in recruited MoMΦs and 
inflammation in wound healing.  These findings may allow for clinical translation via timed 
therapeutic manipulation of CCR2
+
 monocytes in both normal and pathologic wound healing.  For 
example, non-healing type 2 diabetic wounds are characterized by an underlying dysregulation of the 
inflammatory phase of wound healing.  Our lab and others have shown that diabetic mice demonstrate 
poor wound healing as a result of chronic, dysregulated macrophage-mediated inflammation in 
wounds.  Interestingly, we have found that the primary ligand for CCR2, CCL2, is decreased early in 
diabetic wounds[41].  These findings suggest CCL2 as a possible target for the manipulation of the 
CCL2/CCR2 interaction to therapeutically alter the timing of macrophage-mediated inflammation in 
diabetic wounds to improve wound healing.  Our findings show that CCR2 is crucial for the initial 
inflammatory response in tissues, and that the timing of MoMΦs subsets in the wound is integral for 
progression of the wound healing cascade.   
 
MATERIALS AND METHODS 
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of Michigan and all experiments were conducted under approval of the Institutional Animal Care and 
Use Committee (UCUCA), approval number PRO00005974.  C57BL/6 mice  (Jackson Laboratory, 
Bar Harbor, ME) and CCR2
-/-
 (kind gift of Dr. Bethany Moore, University of Michigan) were 
obtained and maintained in breeding pairs by the University of Michigan Unit for Laboratory and 
Animal Medicine (ULAM).  mT/mG mice (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J) were purchased 
from Jackson Laboratory.  All animals underwent procedures at 20 to 32 weeks of age with 
Institutional Animal Care and Use Committee approval.  
Wound Healing Model. Mice were anesthetized with intraperitoneal ketamine/xylazine mixture, 
dorsal hair was removed with Veet Hair Removal Cream, and dorsal skin was cleaned with sterile 
water.  Full thickness 4mm punch biopsy wounds were then created at 2-4 locations on the mid-back 
(two wounds for wound monitoring, and four wounds for cell isolation, RNA, and protein 
experiments). Mice were allowed to recover on a heating pad and then were returned to the housing 
facility once ambulatory.  
Assessment of Wound Healing. An 8mp digital iPad camera was used to monitor wound healing 
over time. Internal scales were used in the photographs and wound area was calculated using NIH 
ImageJ Software (National Institute of Heath, Bethesda, MD). Initial wound size was calculated 
immediately after wounding, and wound closure was assessed over time as a percent of initial wound 
area.  
Wound histology. On day 3 post wounding, whole wounds were excised using a 6mm punch biopsy.  
Wound sections were fixed in 10% formalin overnight before embedding in paraffin.  5μM sections 
were stained with hematoxylin and eosin for evaluation of re-epithelialization and with Masson’s 
Trichrome stain for collagen deposition.  Images were captured using Olympus BX43 microscope and 
Olympus cellSens Dimension software.  Percent re-epithelialization was calculated by measuring 
distance traveled by epithelial tongues on both sides of wound divided by total distance needed for 
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Wound Digestion. Following sacrifice, wounds were collected from the backs of the mice post-
mortem following CO2 asphyxiation using a 6mm wound biopsy.  Sharp scissors were used to excise 
the full thickness dermis with a 1-2mm margin around the wound ensuring collection of granulation 
tissue and wounds were placed in RPMI.  Wounds were then carefully minced with sharp scissors and 
digested by incubating in a 50 mg/ml Liberase TM (Roche) and 20U/ml DNaseI (Sigma-Aldrich) 
solution.  Wound cell suspensions were then gently plunged and filtered through a 100µm filter to 
yield a single cell suspension. Cells were then either MACS sorted for CD11b+ cells for RNA studies 
or cultured ex-vivo for application of GolgiStop and subsequent staining for intracellular flow 
cytometry[37]. 
Magnetic-Assisted Cell Sorting (MACS) of Wound Macrophages. CD11b+ cells were isolated 
from single cell suspensions as previously described[37].  Cell suspensions were incubated with 
FITC-labeled anti-CD19, anti-CD3, and anti-Ly6G magnetic beads (Biolegend) followed by anti-
FITC microbeads (Miltenyi Biotec) and passed over magnetic columns.   The eluent was then 
collected and incubated with anti-CD11b microbeads and passed through a second column to isolate 
CD11b+ cells.  CD11b+ wound isolates were then collected and placed in Trizol® (Invitrogen). 
Quantitative Polymerase Chain Reaction (qPCR). After being placed in Trizol® RNA was isolated 
following the standard protocol using chloroform, isopropyl alcohol, and ethyl alcohol. cDNA was 
then created using either iScript® (BioRad) or Superscript III® Reverse Transcriptase (ThermoFisher 
Scientific).  Quantitative PCR was performed using primers specific for CCL2, IL1β, TNF-α, and 
iNOS (Thermo Fisher Scientic).  All genes were normalized to 18s rRNA (Thermo Fisher Scientic) 
and their expression was analyzed using the 2
∆Ct
 method.  Data was compiled in Microsoft Excel 
(Microsoft) and presented using Prism software (GraphPad). 
Ex-Vivo Flow Culture. For ex-vivo intracellular flow cytometry, single-cell wound suspensions were 
incubated in single-housed Teflon coated wells with RPMI + FBS + Glutamine + Pen/Strep + LPS for 
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transport. After 120 minutes of incubation with GolgiStop, cells were aspirated from the Teflon 
coated wells and washed in PBS prior to staining for analytical flow cytometry.  
Flow Cytometry. Single cell suspensions were collected and washed two times with cold PBS and 
filtered into a 96-well plate for surface staining. Cells were initially stained with pacific orange 
LIVE/DEAD fixable viability dye (Thermofisher) and then washed two times with cold PBS. Cells 
were then resuspended in Flow Buffer (PBS, FBS, NaN3, and Hepes Buffer) and Fc-Receptors were 
blocked with anti-CD16/32 (Biolegend) prior to surface staining. Biotinylated monoclonal antibodies 
used for surface staining included: Anti-CD3, Anti-CD19, Anti-Ter-119, Anti-NK1.1, Anti-CD11b, 
Anti-Ly6G, and Anti-Ly6C (Biolegend). Following surface staining, cells were washed twice, and 
biotinylated antibodies were labeled with streptavidin APC-Cy7. Next, cells were either washed and 
acquired for surface-only flow cytometry, or were fixed with 2% formaldehyde and then 
washed/permeabilized with BD perm/wash buffer (BD Biosciences) for intra-cellular flow cytometry. 
After permeablilization, intra-cellular stains included: anti-IL1β (BD Biosciences), anti-TNF-α 
(Biolegend), anti-iNOS (affymetrix). After washing, samples were then acquired on a 3-Laser 
Novocyte Flow Cytometer (Acea Biosciences, Inc.). Data was analyzed using FlowJo software 
version 10.0 (Treestar, Inc.) and data was compiled using Prism software (GraphPad, Inc.). To verify 
gating and purity, all populations were routinely back-gated. Methods for flow cytometry adhered to 
Guidelines for the use of flow cytometry and cell sorting in immunological studies [42].  
Adoptive transfer.  Two cohorts of CCR2
-/- 





mice were harvested and CD3-, CD11c-, CD19-, Ly6G-, NK1.1- 
CD11b+ cells were isolated using microbeads and magnetic columns as described above.  One million 
cells in 200 μL total volume were injected via tail vein into each mouse within two hours of 
wounding.  One mouse cohort received wild type (CCR2
+/+
) CD11b+ cells while the other received 
CCR2
-/- 
CD11b+ cells for control.  Wound healing was monitored over time and wound area was 
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size was calculated immediately after wounding, and wound closure was assessed over time as a 
percent of initial wound area.  Another adoptive transfer was performed using mT/mG-labeled mice.  
Spleens from mT/mG CCR2
+/+ 













 cells were isolated using microbeads and magnetic columns as described above.  One million 




 mice within two 
hours of wounding.  Flow cytometry was performed on wounds on days 2 and 4 post-injury and 





















 populations.  
Statistical Analysis. Data was analyzed using GraphPad Prism software version 6.0 and the paired 
student’s T-test was used to assess statistical significance. Unless otherwise specified, data is 
expressed as the mean +/- the standard error of the mean (SEM). A P-value of 0.05 or less was 
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Figure 1. Wound healing is impaired in CCR2-deficient mice (CCR2
-/-
).  Wounds were created 
using 4 mm punch biopsies on the backs of CCR2
-/-
 mice and matched controls (CCR2
+/+
). A: The 
change in wound area was recorded daily using ImageJ software (NIH) until complete healing was 
observed. Representative photographs of the wounds of CCR2
-/-
 mice and controls on days 0, 3 and 5 
post-injury are shown (*P < 0.05; **P < 0.01; data is from a single experiment representative of four 
independent experiments with 14 mice per experiment) B: Wounds were harvested on day 3, paraffin 
embedded and sectioned. Sections were stained with hematoxylin and eosin and with Masson’s 
Trichrome stain. Percent re-epithelialization was calculated by measuring distance traveled by 
epithelial tongues on both sides of wound divided by total distance for full re-epithelialization. 
Representative images are shown in 2X magnification (*P < 0.05; data is from a single experiment 
representative of two independent experiments with 10 mice per experiment).  Statistical analysis was 
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Figure 2. Loss of CCR2 in Ly6C
Hi
 monocytes results in decreased inflammatory Ly6C
Hi 
monocyte/macrophages in wound tissue. 
A: Wounds were harvested from CCR2
-/-
 and matched controls on day 3 and processed for ex vivo 












 cells as shown. Flow cytometry 






















) (data is from a single experiment representative of two independent experiments with 10 
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Figure 3. Macrophages isolated from wounds of CCR2
-/-
 mice display decreased inflammatory 
cytokine gene expression and protein levels. A: Wound macrophages were isolated from CCR2
-/-
 









TNF-α and IL1β gene expression in isolated macrophages was measured by qPCR using 18s for 
normalization (*P<0.05; **P < 0.01; n=12, data is representative of two independent experiments). B: 
CCR2
-/-
 and littermate control wounds harvested on day 3 were processed for ex vivo intracellular 
flow cytometry.  Intracellular cytokine quantification by flow cytometry of IL-1β, iNOS, and TNF-α 
in wound macrophages was examined (*P < 0.05, ** P < 0.01; data is representative of two 
independent experiments with 10 mice per experiment). Statistical analysis was performed using a 
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 spleens by MACS and purified cells injected intravenously via tail vein into wounded (day 0) 
CCR2
-/-
 mice. Wound closure was measured daily using ImageJ software (**P < 0.01; data is 
representative of two independent experiments with 15 mice per experiment). B: Representative 




mice on days 0, 2, and 4.  C: Wound macrophages were 








mice on day 2 post-
injury by MACS and gene expression (IL1β, iNOS, and TNF-α) in isolated macrophages was 
measured by qPCR using 18s for normalization (**P < 0.01; ***P<0.0001; data is representative of 













 single cell suspensions were injected via tail vein into wounded (day 
0) CCR2
-/-
 and control mice.   Wounds were harvested on days 2 and 4 and single cell suspensions 














) and subsequent stratification by Ly6C designation is shown (*P < 0.05; n=10; data is 
representative of two independent experiments).  Statistical analysis was performed using a paired 
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Figure 5. Schematic of CCR2-dependent Ly6C
Hi
 cell recruitment to peripheral wounds.  Upon 
initial tissue injury, CCL2, one of the primary ligands for CCR2, is increased in the wound.  This 
ligand binds the CCR2 receptors that are present on Ly6C
Hi 
monocytes, recruiting these cells to the 
wound, allowing initiation of the macrophage-mediated inflammatory phase of wound healing.   
 
 
 
